Volume 16, Issue 6 pp. 595-598

Urinary transforming growth factor-β1 in children with obstructive uropathy

JAKUB ZIEG

Corresponding Author

JAKUB ZIEG

Departments of Paediatrics

Dr Jakub Zieg, Department of Paediatrics, Second Medical School, Charles University Prague, University Hospital Motol, V Úvalu 84, 150 06 Prague, Czech Republic. Email: [email protected]Search for more papers by this author
KVETA BLAHOVA

KVETA BLAHOVA

Departments of Paediatrics

Search for more papers by this author
TOMAS SEEMAN

TOMAS SEEMAN

Departments of Paediatrics

Search for more papers by this author
JIRI BRONSKY

JIRI BRONSKY

Departments of Paediatrics

Search for more papers by this author
HANA DVORAKOVA

HANA DVORAKOVA

Departments of Paediatrics

Search for more papers by this author
MARTA PECHOVA

MARTA PECHOVA

Medical Chemistry and Biochemistry

Search for more papers by this author
JAN JANDA

JAN JANDA

Departments of Paediatrics

Search for more papers by this author
KAREL MATOUSOVIC

KAREL MATOUSOVIC

Internal Medicine, Second Medical School, Charles University Prague, University Hospital Motol, Prague, Czech Republic

Search for more papers by this author
First published: 08 March 2011
Citations: 17

ABSTRACT:

Aim:  Obstructive uropathies (OU) in childhood constitute one of the major causes of chronic renal insufficiency. Transforming growth factor-β1 (TGF-β1) is considered to be the major fibrogenic growth factor. The aim of the present study was to investigate urinary TGF-β1 levels in children with obstructive and non-obstructive uropathies (NOU).

Methods:  This study involved 19 children with OU, 11 children with non-obstructive hydronephrosis and 21 healthy children. Urinary TGF-β1, proteinuria, microalbuminuria and urinary α1-microglobulin were measured, and renal function was assesed. The results were statistically analyzed.

Results:  Mean urinary TGF-β1 concentrations in patients with OU were significantly higher than those with NOU (4.14 ± 0.67 creatinine vs 1.80 ± 0.24 pg/mmol creatinine, P < 0.05) and healthy controls (1.66 ± 0.28 pg/mmol creatinine, P < 0.05). Positive correlations of urinary TGF-β1 concentrations with proteinuria (r = 0.87, P < 0.0001) and urinary α1-microglobulin (r = 0.82, P = 0.0002) were found in patients with OU.

Conclusion:  Children with OU have higher urinary TGF-β1 than children with NOU. Urinary TGF-β1 may be a useful non-invasive tool for the differential diagnosis between OU and NOU in children. A positive correlation of TGF-β1 with markers of renal tissue damage in patients with OU was found.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.